Yusuf A. Oshodi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yusuf A. Oshodi has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Adebola Afolake Adejimi
Department of Community Health and Primary Care, College of Medicine, University of Lagos/Lagos University Teaching Hospital, Lagos, Nigeria
2 shared publications - Aloy Okechukwu Ugwu
Lagos University Teaching Hospital
2 shared publications - Ayokunle Moses Olumodeji
Department of Obstetrics and Gynaecology, Lagos State University College of Medicine, Lagos, Nigeria
2 shared publications - Kehinde Sharafadeen Okunade
Department of Obstetrics & Gynaecology, Lagos University Teaching Hospital, Lagos, Nigeria
2 shared publications - Adaiah Priscillia Soibi-Harry
Affiliation Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GeorgiaUnited States of America
1 shared publication Adedoyin A. Ogunyemi
Department of Community Health and Primary Healthcare, Lagos University Teaching Hospital, Idi-Araba, Lagos, Nigeria
1 shared publication
Latest Publications
- Open Access
- 12 April 2024
- Published by Springer Nature in BMC Public Health
- Vol. 24 (1) , 1-10
Prenatal anaemia and risk of postpartum haemorrhage: a cohort analysis of data from the Predict-PPH study
Background: Most previous clinical studies investigating the connection between prenatal anaemia and postpartum haemorrhage (PPH) have reported conflicting results. Objectives: We examined the association between maternal prenatal anaemia and the risk of PPH in a large cohort of healthy pregnant women in five health institutions in Lagos, Southwest Nigeria. Methods: This was a prospective cohort analysis of data from the Predict-PPH study that was conducted between January and June 2023. The study enrolled n = 1222 healthy pregnant women giving birth in five hospitals in Lagos, Nigeria. The study outcome, WHO-defined PPH, is postpartum blood loss of at least 500 milliliters. We used a multivariable logistic regression model with a backward stepwise conditional approach to examine the association between prenatal anaemia of increasing severity and PPH while adjusting for confounding factors. Results: Of the 1222 women recruited to the Predict-PPH study between January and June 2023, 1189 (97·3%) had complete outcome data. Up to 570 (46.6%) of the enrolled women had prenatal anaemia while 442 (37.2%) of those with complete follow-up data had WHO-defined PPH. After controlling for potential confounding factors, maternal prenatal anaemia was independently associated with PPH (adjusted odds ratio = 1.37, 95% confidence interval: 1.05–1.79). However, on the elimination of interaction effects of coexisting uterine fibroids and mode of delivery on this association, a sensitivity analysis yielded a lack of significant association between prenatal anaemia and PPH (adjusted odds ratio = 1.27, 95% confidence interval: 0.99–1.64). We also recorded no statistically significant difference in the median postpartum blood loss in women across the different categories of anaemia (P = 0.131). Conclusion: Our study revealed that prenatal anaemia was not significantly associated with PPH. These findings challenge the previously held belief of a suspected link between maternal anaemia and PPH. This unique evidence contrary to most previous studies suggests that other factors beyond prenatal anaemia may contribute more significantly to the occurrence of PPH. This highlights the importance of comprehensive assessment and consideration of various maternal health factors in predicting and preventing this life-threatening obstetric complication.
- 12 April 2024
- Published by Springer Nature in BMC Public Health
- Vol. 24 (1) , 1-10
Open AccessPrenatal anaemia and risk of postpartum haemorrhage: a cohort analysis of data from the Predict-PPH study
Background: Most previous clinical studies investigating the connection between prenatal anaemia and postpartum haemorrhage (PPH) have reported conflicting results. Objectives: We examined the association between maternal prenatal anaemia and the risk of PPH in a large cohort of healthy pregnant women in five health institutions in Lagos, Southwest Nigeria. Methods: This was a prospective cohort analysis of data from the Predict-PPH study that was conducted between January and June 2023. The study enrolled n = 1222 healthy pregnant women giving birth in five hospitals in Lagos, Nigeria. The study outcome, WHO-defined PPH, is postpartum blood loss of at least 500 milliliters. We used a multivariable logistic regression model with a backward stepwise conditional approach to examine the association between prenatal anaemia of increasing severity and PPH while adjusting for confounding factors. Results: Of the 1222 women recruited to the Predict-PPH study between January and June 2023, 1189 (97·3%) had complete outcome data. Up to 570 (46.6%) of the enrolled women had prenatal anaemia while 442 (37.2%) of those with complete follow-up data had WHO-defined PPH. After controlling for potential confounding factors, maternal prenatal anaemia was independently associated with PPH (adjusted odds ratio = 1.37, 95% confidence interval: 1.05–1.79). However, on the elimination of interaction effects of coexisting uterine fibroids and mode of delivery on this association, a sensitivity analysis yielded a lack of significant association between prenatal anaemia and PPH (adjusted odds ratio = 1.27, 95% confidence interval: 0.99–1.64). We also recorded no statistically significant difference in the median postpartum blood loss in women across the different categories of anaemia (P = 0.131). Conclusion: Our study revealed that prenatal anaemia was not significantly associated with PPH. These findings challenge the previously held belief of a suspected link between maternal anaemia and PPH. This unique evidence contrary to most previous studies suggests that other factors beyond prenatal anaemia may contribute more significantly to the occurrence of PPH. This highlights the importance of comprehensive assessment and consideration of various maternal health factors in predicting and preventing this life-threatening obstetric complication.
- Open Access
- 23 September 2021
- Published by American Society of Clinical Oncology (ASCO) in JCO Global Oncology
- Vol. 7 (7) , 1418-1425
Impact of Mobile Technologies on Cervical Cancer Screening Practices in Lagos, Nigeria (mHealth-Cervix): A Randomized Controlled Trial
PURPOSE: We assessed the impact of mHealth on Pap test screening uptake and also determined the factors that affect screening uptake among women in Lagos, Nigeria. MATERIALS AND METHODS: A randomized controlled trial was carried out among women in two tertiary health institutions in Lagos, Nigeria, between July 2020 and March 2021. Participants were randomly assigned to either a text message (mHealth) intervention or usual care arm. The main study outcome was the uptake of Pap smear testing within 6 months of enrollment in the study. We tested the associations between two groups of continuous variables using the unpooled independent-sample t-test (normal distribution) and that of two groups of categorical variables with the chi-square (χ2) test. Using a multinomial logistic regression model, we adjusted for relevant sociodemographic and clinical predictors of uptake of Pap smear screening. Statistical significance was defined as P < .05. RESULTS: There was a significantly higher rate of uptake of Pap smear screening among women in the mHealth arm compared with those in the usual care arm (51.0% v 35.7%, P = .031). Following adjustment in the final multivariate model, level of income (odds ratio [OR] = 5.13, 95% CI, 1.55 to 16.95), awareness of Pap smear (OR = 16.26; 95% CI, 2.49 to 76.64), General Outpatient clinic attendance, and introduction of mHealth intervention during follow-up (OR = 4.36; 95% CI, 1.44 to 13.22) were the independent predictors of Pap smear uptake. CONCLUSION: The use of mHealth technologies intervention via short-text message services is a feasible solution for cervical cancer prevention in low- and middle-income countries, and thus, the widespread use of mHealth services by health care providers and policymakers could contribute to the implementation of cervical cancer prevention services in Nigeria and in the settings of other low- and middle-income countries.
- 23 September 2021
- Published by American Society of Clinical Oncology (ASCO) in JCO Global Oncology
- Vol. 7 (7) , 1418-1425
Open AccessImpact of Mobile Technologies on Cervical Cancer Screening Practices in Lagos, Nigeria (mHealth-Cervix): A Randomized Controlled Trial
PURPOSE: We assessed the impact of mHealth on Pap test screening uptake and also determined the factors that affect screening uptake among women in Lagos, Nigeria. MATERIALS AND METHODS: A randomized controlled trial was carried out among women in two tertiary health institutions in Lagos, Nigeria, between July 2020 and March 2021. Participants were randomly assigned to either a text message (mHealth) intervention or usual care arm. The main study outcome was the uptake of Pap smear testing within 6 months of enrollment in the study. We tested the associations between two groups of continuous variables using the unpooled independent-sample t-test (normal distribution) and that of two groups of categorical variables with the chi-square (χ2) test. Using a multinomial logistic regression model, we adjusted for relevant sociodemographic and clinical predictors of uptake of Pap smear screening. Statistical significance was defined as P < .05. RESULTS: There was a significantly higher rate of uptake of Pap smear screening among women in the mHealth arm compared with those in the usual care arm (51.0% v 35.7%, P = .031). Following adjustment in the final multivariate model, level of income (odds ratio [OR] = 5.13, 95% CI, 1.55 to 16.95), awareness of Pap smear (OR = 16.26; 95% CI, 2.49 to 76.64), General Outpatient clinic attendance, and introduction of mHealth intervention during follow-up (OR = 4.36; 95% CI, 1.44 to 13.22) were the independent predictors of Pap smear uptake. CONCLUSION: The use of mHealth technologies intervention via short-text message services is a feasible solution for cervical cancer prevention in low- and middle-income countries, and thus, the widespread use of mHealth services by health care providers and policymakers could contribute to the implementation of cervical cancer prevention services in Nigeria and in the settings of other low- and middle-income countries.
- Open Access
- 12 July 2021
- Published by Sciencedomain International in Journal of Advances in Medicine and Medical Research
- p. 138-147
Cervical Cancer Screening via Self-Sampling for High-Risk Human Papilloma Virus: A Community-Based Pilot Study in Lagos, Nigeria
Background: Cervical cancer is the second most common cancer in women globally after breast cancer. It is a preventable cancer with a well‑defined premalignant phase where treatment could be offered before invasive cancer develops. Objective: To determine the prevalence, socio-demographic characteristics and serotypes of high-risk HPV amongst positive women using self-sampling HPV-based cervical cancer screening. Methods: A cross-sectional pilot study in an urban setting in Lagos, Nigeria where one hundred women, following community-based counselling on cervical cancer and its prevention, underwent cervical cancer screening via self-sampling for hr-HPV. Structured questionnaires were administered for data collection. Appropriate instruction for self-sample collection using Flobam cervical sampling kit was given to each subject. The samples were processed using DNA analysis via PCR (polymerase chain reaction) amplification and flow through hybridization to identify the hr-HPV serotypes. Women who tested positive for hr-HPV had colposcopic-guided biopsy. The data obtained were analysed using SPSS version 20.0. Findings: Almost all (97%) the women were successful at self-sampling. The prevalence of hr-HPV positivity was 19% with peak (31.6%) of hr-HPV positivity observed in subjects aged 31-40 years. HPV 53 was the commonest (36%) serotype, HPV 33 and 39 were the least (7%) identified and 47% of hr-HPV positive subjects had infection with two or more HPV serotypes. Two-third (66.7%) of hr-HPV positive subjects attended follow-up for colposcopy guided biopsy and 10.5% of the hr-HPV positive subjects had premalignant/malignant cervical lesion. Conclusion: Infection with more than one hr-HPV serotype is common in our study. Self-sampling modality of HPV cervical cancer screening is feasible in this environment.
- 12 July 2021
- Published by Sciencedomain International in Journal of Advances in Medicine and Medical Research
- p. 138-147
Open AccessCervical Cancer Screening via Self-Sampling for High-Risk Human Papilloma Virus: A Community-Based Pilot Study in Lagos, Nigeria
Background: Cervical cancer is the second most common cancer in women globally after breast cancer. It is a preventable cancer with a well‑defined premalignant phase where treatment could be offered before invasive cancer develops. Objective: To determine the prevalence, socio-demographic characteristics and serotypes of high-risk HPV amongst positive women using self-sampling HPV-based cervical cancer screening. Methods: A cross-sectional pilot study in an urban setting in Lagos, Nigeria where one hundred women, following community-based counselling on cervical cancer and its prevention, underwent cervical cancer screening via self-sampling for hr-HPV. Structured questionnaires were administered for data collection. Appropriate instruction for self-sample collection using Flobam cervical sampling kit was given to each subject. The samples were processed using DNA analysis via PCR (polymerase chain reaction) amplification and flow through hybridization to identify the hr-HPV serotypes. Women who tested positive for hr-HPV had colposcopic-guided biopsy. The data obtained were analysed using SPSS version 20.0. Findings: Almost all (97%) the women were successful at self-sampling. The prevalence of hr-HPV positivity was 19% with peak (31.6%) of hr-HPV positivity observed in subjects aged 31-40 years. HPV 53 was the commonest (36%) serotype, HPV 33 and 39 were the least (7%) identified and 47% of hr-HPV positive subjects had infection with two or more HPV serotypes. Two-third (66.7%) of hr-HPV positive subjects attended follow-up for colposcopy guided biopsy and 10.5% of the hr-HPV positive subjects had premalignant/malignant cervical lesion. Conclusion: Infection with more than one hr-HPV serotype is common in our study. Self-sampling modality of HPV cervical cancer screening is feasible in this environment.
- 1 December 2016
- Published by SAGE Publications in Journal of Gynecologic Surgery
- Vol. 32 (6) , 335-338
Hysterectomy in a Southwestern Tertiary Unit in Nigeria: A 5-Year Review
Background: Hysterectomy is one of the commonest major gynecologic surgeries performed worldwide. While the procedure is highly successful for curing diseases, especially nonmalignant conditions, it is not without risks. Objective: The aim of this research was to review hysterectomies in Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria, with respect to indications, types, outcomes, and complications over a 5-year period. Materials and Methods: This was a descriptive retrospective study conducted from January 1, 2005 to December 31, 2009. Case records of patients who underwent hysterectomy were retrieved to obtain information on sociodemographics, types of hysterectomy, elective or emergency surgeries, blood losses, blood units transfused, and surgical complications. Results: Of 1859 major gynecologic surgeries during the study period, there were 196 hysterectomies, an incidence of 10.5%. Mean ages of the patients were 46.83 ± 9.18 years (elective surgery) and 40.28 ± 6.82 years (emergency surgery). Mean parity was 3.67 ± 2.06 for elective surgery and 3.86 ± 0.9 for emergency surgery. Uterine fibroid was the commonest indication at 61.44%, followed by ovarian mass at 7.84%. Mean blood loss was higher (3510 ± 1384) mL in emergency surgery, compared to (886.6 ± 587) mL in elective surgery (p = 0.023). Thus, the mean unit of blood transfusion was 6.57 ± 2.23 units in emergency surgery versus 1.82 ± 2.0 units in elective surgery (p = 0.031). Complications included hemorrhage at 8.3%, urinary tract infection at 3.5%, wound infection at 2.1% and intestinal obstruction at 0.7%. Three death (1.8%) were all attributed to severe hemorrhage. Conclusions: To achieve the most favorable outcome, appropriateness of the surgery must be evaluated carefully along with available options in the context of the patient's disease process. (J GYNECOL SURG 32:335)
- 1 December 2016
- Published by SAGE Publications in Journal of Gynecologic Surgery
- Vol. 32 (6) , 335-338
Hysterectomy in a Southwestern Tertiary Unit in Nigeria: A 5-Year Review
Background: Hysterectomy is one of the commonest major gynecologic surgeries performed worldwide. While the procedure is highly successful for curing diseases, especially nonmalignant conditions, it is not without risks. Objective: The aim of this research was to review hysterectomies in Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria, with respect to indications, types, outcomes, and complications over a 5-year period. Materials and Methods: This was a descriptive retrospective study conducted from January 1, 2005 to December 31, 2009. Case records of patients who underwent hysterectomy were retrieved to obtain information on sociodemographics, types of hysterectomy, elective or emergency surgeries, blood losses, blood units transfused, and surgical complications. Results: Of 1859 major gynecologic surgeries during the study period, there were 196 hysterectomies, an incidence of 10.5%. Mean ages of the patients were 46.83 ± 9.18 years (elective surgery) and 40.28 ± 6.82 years (emergency surgery). Mean parity was 3.67 ± 2.06 for elective surgery and 3.86 ± 0.9 for emergency surgery. Uterine fibroid was the commonest indication at 61.44%, followed by ovarian mass at 7.84%. Mean blood loss was higher (3510 ± 1384) mL in emergency surgery, compared to (886.6 ± 587) mL in elective surgery (p = 0.023). Thus, the mean unit of blood transfusion was 6.57 ± 2.23 units in emergency surgery versus 1.82 ± 2.0 units in elective surgery (p = 0.031). Complications included hemorrhage at 8.3%, urinary tract infection at 3.5%, wound infection at 2.1% and intestinal obstruction at 0.7%. Three death (1.8%) were all attributed to severe hemorrhage. Conclusions: To achieve the most favorable outcome, appropriateness of the surgery must be evaluated carefully along with available options in the context of the patient's disease process. (J GYNECOL SURG 32:335)